Stockpolly
Search
MGX · NASDAQ · Biotechnology

Metagenomi Therapeutics (MGX)

Develops genetic medicines from microbial genome-editing systems.

$1.17
At close0.00 (0.00%)
Watchlist

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue121211201210499410
Cost of revenue27253100025231110
Gross profit−14−12−20201210−21−147300
8893734307730272529
Research & development272531282623252324221923
889987776576
General & administrative889987776076
Other expenses−27−25−31000−25−2300−10
Operating income−22−20−29−17−22−21−28−21−23−24−25−29
44442−4312221
Interest income444443322221
Other non-operating income−4−4−4−4−24−3−1−2−2−2−1
Income before tax−19−17−25−13−21−25−25−20−21−22−23−27
Income tax expense130−2−2−1000000
Net income from continuing operations−20−19−25−11−19−23−25−20−20−23−23−27
Other adjustments000000000000
Net income−20−19−25−11−19−23−25−20−20−23−23−27
EPS, basic−$0.53−$0.51−$0.67−$0.29−$0.51−$0.63−$0.68−$0.54−$0.55−$0.60−$0.61−$0.73
EPS, diluted−$0.53−$0.51−$0.67−$0.29−$0.51−$0.63−$0.68−$0.54−$0.55−$0.60−$0.61−$0.73
Weighted average shares, basic373737373737373737383838
Weighted average shares, diluted373737373737373737383838
EBITDA−17−15−24−12−20−23−24−19−19−21−22−26
Depreciation & amortization111111111111
EBIT−19−17−25−13−21−25−25−20−21−22−23−27